Press Releases

CHELMSFORD, Mass., Jan. 6, 2020 /PRNewswire/ -- Brooks Automation, Inc. (Nasdaq:BRKS) announced today that company management will participate in the 22nd Annual Needham Growth Conference at the Lotte New York Palace hotel.  Lindon Robertson, EVP and CFO, will be presenting on Tuesday, January 14th at

WESTON, Fla., Jan. 6, 2020 /PRNewswire/ -- ZyVersa Therapeutics, Inc. (ZyVersa), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for treatment of renal and inflammatory diseases, is pleased to announce that Stephen C. Glover, ZyVersa's Co-Founder, Chief Executive Officer, and President, will attend

CARLSBAD, Calif., Jan. 6, 2020 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, today announced that Brett P. Monia, Ph.D., chief executive officer, will present a company overview at the 38th annual J.P. Morgan Healthcare Conference on Wednesday, Jan. 15,

NEWARK, Calif., Jan. 6, 2020 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today announced that a Phase 2 study of its novel hepcidin mimetic PTG-300 in patients with hereditary hemochromatosis has been initiated. Hereditary hemochromatosis is a blood disorder that causes the body to absorb too much iron from the diet, resulting in the accumulation of

DUBLIN, Jan. 6, 2020 /PRNewswire/ -- Allergan plc (NYSE: AGN), today announced that its Warner Chilcott and Watson subsidiaries have reached resolutions with all plaintiffs, including a class of direct purchasers, individual direct purchasers that previously opted out of the direct purchaser class, and a class of indirect purchasers of

LITTLE FALLS, N.J., Jan. 6, 2020 /PRNewswire/ -- CANTEL MEDICAL CORP. (NYSE: CMD) announced today that George Fotiades, President and CEO, will be presenting at the 38th annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco. The formal presentation i

ROCKLAND, Mass. and NEW YORK, Jan. 6, 2020 /PRNewswire/ -- EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany in the US and Canada, and Pfizer Inc. (NYSE: PFE) today announced the Phase III JAVELIN Bladder 100 study met its primary endpoint of

LAVAL, Quebec, Jan. 6, 2020 /PRNewswire/ -- Bausch Health Companies Inc. (NYSE/TSX: BHC) today announced that Joseph C. Papa, chairman and chief executive officer, is scheduled to participate at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, Ja

SCOTTSDALE, Ariz., Jan. 6, 2020 /PRNewswire/ -- Vitalant, one of the largest national nonprofit blood banks, is declaring a critical shortage of blood. Vitalant serves patients in 40 states from California to New Jersey and Texas to Washington

SAN JOSE, Calif., Jan. 6, 2020 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on harnessing the body's immune system in the fight against cance